Top Markets
#1 MowCat MowCat +48.84%
#2 Velvet Velvet +22.73%
#3 Fake World Assets Fake World Assets +21.43%
#4 Quack AI Quack AI +18.90%
#5 Perle Perle +18.80%
#6 Block Street Block Street +17.95%
#7 Bermuda Shorts Bermuda Shorts +16.76%
#8 Derive Derive +15.58%
#9 龙虾 (Lobster) 龙虾 (Lobster) +12.63%
#10 Epic Chain Epic Chain +12.26%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
GeneTether Therapeutics Inc. GeneTether Therapeutics Inc.

GeneTether Therapeutics Inc.

GTTX
Clasificación en acciones #34710
GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in... GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in genetic medicines. Its primary focus is the advancement of gene-editing therapies, aiming to significantly boost the effectiveness of current genomic modification techniques. The company's pipeline is dedicated to engineering genetic treatments for individuals suffering from rare, single-gene disorders affecting the kidneys and skin. Established in 2018, GeneTether Therapeutics Inc. is headquartered in Kelowna, Canada.
Precio por acción
$0.10409799
Última sincronización: 2025-02-03
Capitalización bursátil
$5.07M
Cambio (1 día)
16.43%
Cambio (1 año)
0.00%
País
CA
Comercio GeneTether Therapeutics Inc. (GTTX)

Categoría

Healthcare
Ratio P/B de GeneTether Therapeutics Inc. (GTTX)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de GeneTether Therapeutics Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de GeneTether Therapeutics Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE